Add to ORKGEvidence supporting the use of drug-eluting stents (DES) in saphenous vein graft (SVG) disease is uncertain. Previous studies have suggested that DES might reduce the re-intervention rate in SVG disease, with conflicting data on mortality. Thus, a meta-analysis was performed to compare outcomes of DES vs. bare metal stent (BMS) in SVG disease
ObjectivesThe purpose of this study was to evaluate the long-term safety and effectiveness of drug-e...
AbstractObjectiveTo evaluate the long-term clinical results of bare stents (BMS) and drug eluting st...
OBJECTIVES: The aim of the study was to compare outcomes of drug-eluting stents (DES) versus bare-m...
This meta-analysis was undertaken to assess the efficacy and safety of drug-eluting stents (DESs) co...
AIMS: Treatment of saphenous vein graft (SVG) disease is still a matter of debate given the uncertai...
Saphenous vein grafts develop an aggressive atherosclerotic process and the efficacy of drug eluting...
Background: Drug eluting stents (DES) are preferred over bare metal stents (BMS) for native coronary...
Conflicting data exist regarding an advantage of drug-eluting stents (DES) over bare metal stents (B...
AIMS: Studies demonstrate that percutaneous coronary intervention (PCI) with drug-eluting stents (DE...
ObjectivesThis study compares outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) i...
Few studies have examined the efficacy of drug-eluting stents (DES) for reducing aortocoronary saphe...
Background Long-term safety and efficacy data of drug-eluting stents (DESs) in saphenous vein grafts...
Objectives The aim of the study was to compare outcomes of drug-eluting stents (DES) versus bare-met...
Background: Drug-eluting stents (DES) reduce target lesion revascularization (TLR) with no effect on...
AbstractBackgroundStenosis of saphenous vein grafts (SVGs) after coronary artery bypass grafting (CA...
ObjectivesThe purpose of this study was to evaluate the long-term safety and effectiveness of drug-e...
AbstractObjectiveTo evaluate the long-term clinical results of bare stents (BMS) and drug eluting st...
OBJECTIVES: The aim of the study was to compare outcomes of drug-eluting stents (DES) versus bare-m...
This meta-analysis was undertaken to assess the efficacy and safety of drug-eluting stents (DESs) co...
AIMS: Treatment of saphenous vein graft (SVG) disease is still a matter of debate given the uncertai...
Saphenous vein grafts develop an aggressive atherosclerotic process and the efficacy of drug eluting...
Background: Drug eluting stents (DES) are preferred over bare metal stents (BMS) for native coronary...
Conflicting data exist regarding an advantage of drug-eluting stents (DES) over bare metal stents (B...
AIMS: Studies demonstrate that percutaneous coronary intervention (PCI) with drug-eluting stents (DE...
ObjectivesThis study compares outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) i...
Few studies have examined the efficacy of drug-eluting stents (DES) for reducing aortocoronary saphe...
Background Long-term safety and efficacy data of drug-eluting stents (DESs) in saphenous vein grafts...
Objectives The aim of the study was to compare outcomes of drug-eluting stents (DES) versus bare-met...
Background: Drug-eluting stents (DES) reduce target lesion revascularization (TLR) with no effect on...
AbstractBackgroundStenosis of saphenous vein grafts (SVGs) after coronary artery bypass grafting (CA...
ObjectivesThe purpose of this study was to evaluate the long-term safety and effectiveness of drug-e...
AbstractObjectiveTo evaluate the long-term clinical results of bare stents (BMS) and drug eluting st...
OBJECTIVES: The aim of the study was to compare outcomes of drug-eluting stents (DES) versus bare-m...